Caprock Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | $2.53M | Buy |
34,444
+6,715
| +24% | +$494K | 0.08% | 230 |
|
2024
Q4 | $1.82M | Buy |
27,729
+3,600
| +15% | +$236K | 0.06% | 287 |
|
2024
Q3 | $1.88M | Buy |
24,129
+87
| +0.4% | +$6.78K | 0.07% | 245 |
|
2024
Q2 | $1.88M | Buy |
24,042
+13,592
| +130% | +$1.06M | 0.08% | 222 |
|
2024
Q1 | $708K | Buy |
10,450
+1,239
| +13% | +$83.9K | 0.04% | 319 |
|
2023
Q4 | $620K | Sell |
9,211
-1,896
| -17% | -$128K | 0.04% | 340 |
|
2023
Q3 | $752K | Buy |
11,107
+262
| +2% | +$17.7K | 0.06% | 264 |
|
2023
Q2 | $776K | Buy |
10,845
+625
| +6% | +$44.7K | 0.06% | 265 |
|
2023
Q1 | $709K | Buy |
10,220
+1,711
| +20% | +$119K | 0.06% | 270 |
|
2022
Q4 | $577K | Sell |
8,509
-24
| -0.3% | -$1.63K | 0.05% | 255 |
|
2022
Q3 | $468K | Sell |
8,533
-929
| -10% | -$51K | 0.05% | 289 |
|
2022
Q2 | $625K | Sell |
9,462
-181
| -2% | -$12K | 0.06% | 228 |
|
2022
Q1 | $640K | Buy |
9,643
+3,015
| +45% | +$200K | 0.06% | 246 |
|
2021
Q4 | $386K | Sell |
6,628
-1,926
| -23% | -$112K | 0.03% | 350 |
|
2021
Q3 | $514K | Buy |
8,554
+2,438
| +40% | +$146K | 0.05% | 251 |
|
2021
Q2 | $366K | Sell |
6,116
-5,493
| -47% | -$329K | 0.03% | 309 |
|
2021
Q1 | $577K | Sell |
11,609
-673
| -5% | -$33.5K | 0.06% | 217 |
|
2020
Q4 | $614K | Buy |
12,282
+2,211
| +22% | +$111K | 0.07% | 204 |
|
2020
Q3 | $552K | Buy |
10,071
+1,127
| +13% | +$61.8K | 0.08% | 188 |
|
2020
Q2 | $473K | Sell |
8,944
-163
| -2% | -$8.62K | 0.07% | 203 |
|
2020
Q1 | $407K | Buy |
9,107
+2,695
| +42% | +$120K | 0.08% | 181 |
|
2019
Q4 | $320K | Buy |
6,412
+138
| +2% | +$6.89K | 0.06% | 237 |
|
2019
Q3 | $280K | Buy |
6,274
+568
| +10% | +$25.3K | 0.05% | 249 |
|
2019
Q2 | $236K | Sell |
5,706
-653
| -10% | -$27K | 0.05% | 272 |
|
2019
Q1 | $257K | Buy |
6,359
+644
| +11% | +$26K | 0.05% | 288 |
|
2018
Q4 | $217K | Buy |
+5,715
| New | +$217K | 0.05% | 297 |
|
2016
Q4 | – | Sell |
-10,800
| Closed | -$355K | – | 347 |
|
2016
Q3 | $355K | Buy |
10,800
+828
| +8% | +$27.2K | 0.08% | 227 |
|
2016
Q2 | $301K | Sell |
9,972
-1,470
| -13% | -$44.4K | 0.07% | 212 |
|
2016
Q1 | $322K | Buy |
+11,442
| New | +$322K | 0.08% | 217 |
|